467 related articles for article (PubMed ID: 27384379)
21. Leukocyte telomere length predicts cancer risk in Barrett's esophagus.
Risques RA; Vaughan TL; Li X; Odze RD; Blount PL; Ayub K; Gallaher JL; Reid BJ; Rabinovitch PS
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2649-55. PubMed ID: 18086770
[TBL] [Abstract][Full Text] [Related]
22. Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review.
Shaheen N; Ransohoff DF
JAMA; 2002 Apr; 287(15):1972-81. PubMed ID: 11960540
[TBL] [Abstract][Full Text] [Related]
23. Role of obesity in Barrett's esophagus and cancer.
Murray L; Romero Y
Surg Oncol Clin N Am; 2009 Jul; 18(3):439-52. PubMed ID: 19500735
[TBL] [Abstract][Full Text] [Related]
24. Metabolic syndrome in relation to Barrett's esophagus and esophageal adenocarcinoma: Results from a large population-based case-control study in the Clinical Practice Research Datalink.
Drahos J; Li L; Jick SS; Cook MB
Cancer Epidemiol; 2016 Jun; 42():9-14. PubMed ID: 26972225
[TBL] [Abstract][Full Text] [Related]
25. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.
Avidan B; Sonnenberg A; Schnell TG; Chejfec G; Metz A; Sontag SJ
Am J Gastroenterol; 2002 Aug; 97(8):1930-6. PubMed ID: 12190156
[TBL] [Abstract][Full Text] [Related]
26. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma.
Weston AP; Badr AS; Topalovski M; Cherian R; Dixon A; Hassanein RS
Am J Gastroenterol; 2000 Feb; 95(2):387-94. PubMed ID: 10685740
[TBL] [Abstract][Full Text] [Related]
27. Age-specific risk factor profiles of adenocarcinomas of the esophagus: A pooled analysis from the international BEACON consortium.
Drahos J; Xiao Q; Risch HA; Freedman ND; Abnet CC; Anderson LA; Bernstein L; Brown L; Chow WH; Gammon MD; Kamangar F; Liao LM; Murray LJ; Ward MH; Ye W; Wu AH; Vaughan TL; Whiteman DC; Cook MB
Int J Cancer; 2016 Jan; 138(1):55-64. PubMed ID: 26175109
[TBL] [Abstract][Full Text] [Related]
28. Gender difference in gastro-esophageal reflux diseases.
Asanuma K; Iijima K; Shimosegawa T
World J Gastroenterol; 2016 Feb; 22(5):1800-10. PubMed ID: 26855539
[TBL] [Abstract][Full Text] [Related]
29. Development and Validation of a Model to Determine Risk of Progression of Barrett's Esophagus to Neoplasia.
Parasa S; Vennalaganti S; Gaddam S; Vennalaganti P; Young P; Gupta N; Thota P; Cash B; Mathur S; Sampliner R; Moawad F; Lieberman D; Bansal A; Kennedy KF; Vargo J; Falk G; Spaander M; Bruno M; Sharma P
Gastroenterology; 2018 Apr; 154(5):1282-1289.e2. PubMed ID: 29273452
[TBL] [Abstract][Full Text] [Related]
30. Esophageal adenocarcinoma arising after antireflux surgery: a population-based analysis.
Kauttu TM; Rantanen TK; Sihvo EI; Räsänen JV; Puolakkainen P; Salo JA
Eur J Cardiothorac Surg; 2011 Dec; 40(6):1450-4; discussion 1454. PubMed ID: 21546258
[TBL] [Abstract][Full Text] [Related]
31. Alcohol and the risk of Barrett's esophagus: a pooled analysis from the International BEACON Consortium.
Thrift AP; Cook MB; Vaughan TL; Anderson LA; Murray LJ; Whiteman DC; Shaheen NJ; Corley DA
Am J Gastroenterol; 2014 Oct; 109(10):1586-94. PubMed ID: 25047401
[TBL] [Abstract][Full Text] [Related]
32. Etiology of Barrett's metaplasia and esophageal adenocarcinoma.
Kim R; Weissfeld JL; Reynolds JC; Kuller LH
Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):369-77. PubMed ID: 9149898
[TBL] [Abstract][Full Text] [Related]
33. Increasing prevalence of high-grade dysplasia and adenocarcinoma on index endoscopy in Barrett's esophagus over the past 2 decades: data from a multicenter U.S. consortium.
Desai M; Lieberman DA; Kennedy KF; Hamade N; Thota P; Parasa S; Gorrepati VS; Bansal A; Gupta N; Gaddam S; Young PE; Mathur S; Moawad FJ; Cash BD; Sampliner R; Vargo JJ; Falk GW; Sharma P
Gastrointest Endosc; 2019 Feb; 89(2):257-263.e3. PubMed ID: 30342028
[TBL] [Abstract][Full Text] [Related]
34. Barrett associated MHC and FOXF1 variants also increase esophageal carcinoma risk.
Dura P; van Veen EM; Salomon J; te Morsche RH; Roelofs HM; Kristinsson JO; Wobbes T; Witteman BJ; Tan AC; Drenth JP; Peters WH
Int J Cancer; 2013 Oct; 133(7):1751-5. PubMed ID: 23504527
[TBL] [Abstract][Full Text] [Related]
35. Telomere Shortening of Barrett's Esophagus and Esophageal Adenocarcinoma in Japanese Patients.
Tahara T; Shijimaya T; Yamazaki J; Tomiyama T; Fukui T; Naganuma M
Cancer Invest; 2023 Sep; 41(7):640-645. PubMed ID: 37548421
[TBL] [Abstract][Full Text] [Related]
36. Determination of risk for Barrett's esophagus and esophageal adenocarcinoma.
Thrift AP
Curr Opin Gastroenterol; 2016 Jul; 32(4):319-24. PubMed ID: 27276368
[TBL] [Abstract][Full Text] [Related]
37. Global prevalence of Barrett's oesophagus and oesophageal cancer in individuals with gastro-oesophageal reflux: a systematic review and meta-analysis.
Eusebi LH; Cirota GG; Zagari RM; Ford AC
Gut; 2021 Mar; 70(3):456-463. PubMed ID: 32732370
[TBL] [Abstract][Full Text] [Related]
38. Interactions Between Genetic Variants and Environmental Factors Affect Risk of Esophageal Adenocarcinoma and Barrett's Esophagus.
Dong J; Levine DM; Buas MF; Zhang R; Onstad L; Fitzgerald RC; ; Corley DA; Shaheen NJ; Lagergren J; Hardie LJ; Reid BJ; Iyer PG; Risch HA; Caldas C; Caldas I; Pharoah PD; Liu G; Gammon MD; Chow WH; Bernstein L; Bird NC; Ye W; Wu AH; Anderson LA; MacGregor S; Whiteman DC; Vaughan TL; Thrift AP
Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1598-1606.e4. PubMed ID: 29551738
[TBL] [Abstract][Full Text] [Related]
39. Epidemiology of Barrett's esophagus.
Cameron AJ
Gastroenterol Clin Biol; 1994; 18(1 Pt 2):D3-4. PubMed ID: 8013779
[No Abstract] [Full Text] [Related]
40. [Barrett's esophagus and Helicobacter pylori].
Sakata H; Fujimoto K
Nihon Rinsho; 2005 Aug; 63(8):1383-6. PubMed ID: 16101226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
